Ferroptosis, a distinct form of regulated cell death, is characterized by the iron-dependent accumulation of lipid peroxides, leading to oxidative damage and cell membrane rupture. Unlike apoptosis or necrosis, ferroptosis presents unique morphological and biochemical features, positioning it as a significant area of interest in cancer research. The tumor immune microenvironment (TIME) is a complex ecosystem where cancer cells interact with immune cells, stromal components, and soluble factors. Within this environment, ferroptosis has emerged as a potential dual player, acting both as a driver of tumorigenesis and a modulator of immune responses. Recent studies highlight the intricate interplay between ferroptosis and the TIME, suggesting that this interaction contributes to a pro-tumorigenic environment. However, the immunomodulatory effects of ferroptotic cell death may also enhance antitumor immune responses. Despite these insights, the precise mechanisms governing ferroptosis within the TIME remain inadequately understood, necessitating further investigation to fully exploit its therapeutic potential.
This research topic aims to explore the multifaceted roles of ferroptosis within the tumor immune microenvironment, focusing on its regulatory mechanisms, impact on tumor progression, and implications for therapeutic interventions. By examining the connections between ferroptosis and immune responses, the research seeks to uncover novel pathways for precision medicine and therapeutic exploitation. Key questions include how ferroptosis influences immune cell behavior, the molecular pathways involved, and the potential for integrating ferroptosis modulation with existing cancer therapies.
To gather further insights into the complex interactions between ferroptosis and the tumor immune microenvironment, we welcome articles addressing, but not limited to, the following themes:
- Tumor Immunology: Investigating the role of ferroptosis in cancer-immune cell interactions, including immune evasion and resistance mechanisms.
- Programmed Cell Death Mechanisms: Exploring the molecular pathways regulating ferroptosis in the context of cancer immunotherapy.
- Immunotherapy: Examining novel immunotherapeutic approaches and their synergistic effects with ferroptosis inducers.
- Stromal Cells and TME Modulation: Understanding the influence of stromal cells and extracellular matrix components on ferroptosis mechanisms.
- Cancer Metabolism: Investigating the impact of metabolic reprogramming on ferroptosis pathways, including nutrient availability and metabolic stress.
- Clinical Translational Research: Evaluating the efficacy and safety of therapeutic strategies targeting ferroptosis in cancer patients, with a focus on personalized medicine approaches.
Ferroptosis, a distinct form of regulated cell death, is characterized by the iron-dependent accumulation of lipid peroxides, leading to oxidative damage and cell membrane rupture. Unlike apoptosis or necrosis, ferroptosis presents unique morphological and biochemical features, positioning it as a significant area of interest in cancer research. The tumor immune microenvironment (TIME) is a complex ecosystem where cancer cells interact with immune cells, stromal components, and soluble factors. Within this environment, ferroptosis has emerged as a potential dual player, acting both as a driver of tumorigenesis and a modulator of immune responses. Recent studies highlight the intricate interplay between ferroptosis and the TIME, suggesting that this interaction contributes to a pro-tumorigenic environment. However, the immunomodulatory effects of ferroptotic cell death may also enhance antitumor immune responses. Despite these insights, the precise mechanisms governing ferroptosis within the TIME remain inadequately understood, necessitating further investigation to fully exploit its therapeutic potential.
This research topic aims to explore the multifaceted roles of ferroptosis within the tumor immune microenvironment, focusing on its regulatory mechanisms, impact on tumor progression, and implications for therapeutic interventions. By examining the connections between ferroptosis and immune responses, the research seeks to uncover novel pathways for precision medicine and therapeutic exploitation. Key questions include how ferroptosis influences immune cell behavior, the molecular pathways involved, and the potential for integrating ferroptosis modulation with existing cancer therapies.
To gather further insights into the complex interactions between ferroptosis and the tumor immune microenvironment, we welcome articles addressing, but not limited to, the following themes:
- Tumor Immunology: Investigating the role of ferroptosis in cancer-immune cell interactions, including immune evasion and resistance mechanisms.
- Programmed Cell Death Mechanisms: Exploring the molecular pathways regulating ferroptosis in the context of cancer immunotherapy.
- Immunotherapy: Examining novel immunotherapeutic approaches and their synergistic effects with ferroptosis inducers.
- Stromal Cells and TME Modulation: Understanding the influence of stromal cells and extracellular matrix components on ferroptosis mechanisms.
- Cancer Metabolism: Investigating the impact of metabolic reprogramming on ferroptosis pathways, including nutrient availability and metabolic stress.
- Clinical Translational Research: Evaluating the efficacy and safety of therapeutic strategies targeting ferroptosis in cancer patients, with a focus on personalized medicine approaches.